ENVB logo

Enveric Biosciences, Inc. (ENVB)

Profile

Full Name

Enveric Biosciences, Inc.

Ticker

NASDAQ: ENVB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 4, 2015

Indexes

Not included

Website

https://www.enveric.com

Employees

5

Key Details

Price

$0.90(-1.21%)

Market cap

Last Dividend

$15.75K

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$19.04(-135.35% YoY)

PE ratio

-

Next earnings date

Nov 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.90
    ENVB price is $0.90

    30-Day Relative Volume

    0.37
    ENVB 30-day relative volume is 0.37

    Price Performance

    Price Most recent change

    -1.21%
    ENVB price was down -1.21% on Sep 8, 2025

    Price YTD change

    -98.88%
    ENVB price is down -98.88% since January 1st

    Price 1-year change

    -99.22%
    ENVB price is down -99.22% year-on-year

    Price 3-year change

    -99.93%
    ENVB price is down -99.93% over the past 3 years

    Price Range

    Price All-time high

    $10.13M
    ENVB price is currently -100.00% below its historical high of $10.13 million

    Price 3-year low

    $0.30
    ENVB price is currently +203.72% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.92M
    ENVB market capitalization is $2.92 million

    Market cap 3-year change

    -97.72%
    ENVB market capitalization is down -97.72% over the past 3 years

    Market cap All-time high

    $2.02B
    ENVB market capitalization is currently -99.86% below its historical high of $2.02 billion

    Market cap sector rank

    6.8%
    ENVB market capitalization is higher than 6.8% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +445.87%
    ENVB shares outstanding is up +445.87% year-on-year

    Shares Outstanding 3-Year Change

    +2991.71%
    ENVB shares outstanding is up +2991.71% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.76
    ENVB beta is 1.76

    200-day SMA

    $18.90
    ENVB price is currently -95.24% below its 200-day simple moving average

    50-day SMA

    $1.21
    ENVB price is currently -25.81% below its 50-day simple moving average

    RSI

    32.47
    ENVB 14-day relative strength index is 32.47

    Volume

    0.37
    ENVB 30-day relative volume is 0.37

    ATR

    $0.10
    ENVB average true range is $0.10

    10-day Historical Volatility

    117.44%
    ENVB 10-day historical volatility is 117.44%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $15.75 thousand
    ENVB last dividend was $15.75 thousand per share, with an ex-dividend date of April 23, 2008

    Next Dividend

    -
    ENVB next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    ENVB annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    ENVB annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    ENVB annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    ENVB annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    ENVB annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    ENVB annual dividend yield is unknown

    Other

    Payout ratio

    0.00%
    ENVB annual payout ratio is 0.00%

    Dividends paid

    $0.00
    ENVB annual dividends paid is $0.00

    Free cash flow

    -$7.73M
    ENVB annual free cash flow is -$7.73 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ENVB annual revenue is $0.00

    Revenue Analysts estimate

    -
    ENVB annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    ENVB annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    ENVB annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$19.04
    ENVB annual earnings per share is -$19.04

    EPS Analysts estimate

    -
    ENVB annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -135.35%
    ENVB annual earnings per share is down -135.35% year-on-year

    EPS Sector rank

    8.24%
    ENVB annual earnings per share is higher than 8.24% of companies in Healthcare sector

    Profit

    Gross profit

    -$337.50K
    ENVB annual gross profit is -$337.50 thousand

    Gross margin

    -
    ENVB annual gross profit margin value is unknown

    Operating profit

    -$9.63M
    ENVB annual operating income is -$9.63 million

    Operating margin

    -
    ENVB annual operating profit margin value is unknown

    Net income

    -$9.57M
    ENVB annual net profit is -$9.57 million

    Net margin

    -
    ENVB annual net profit margin value is unknown

    Expenses

    Total expenses

    $9.63M
    ENVB annual total expenses is $9.63 million

    Operating expenses

    $9.63M
    ENVB annual total operating expenses is $9.63 million

    Cost of goods sold

    $337.50K
    ENVB annual cost of goods sold is $337.50 thousand

    Selling, general & administrative expenses

    $6.45M
    ENVB annual SGA is $6.45 million

    Depreciation and amortization

    $337.50K
    ENVB annual depreciation & amortization is $337.50 thousand

    Interest expense

    $0.00
    ENVB annual interest expense is $0.00

    Income tax

    $8900.00
    ENVB annual income tax is $8900.00

    EBIT & EBITDA

    EBIT

    -$9.63M
    ENVB annual earnings before interest & taxes is -$9.63 million

    EBITDA

    -$9.29M
    ENVB annual EBITDA is -$9.29 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $3.08M
    ENVB annual total assets is $3.08 million

    Non current assets

    $348.00K
    ENVB annual long term assets is $348.00 thousand

    Current assets

    $2.73M
    ENVB annual total current assets is $2.73 million

    Cash and cash equivalents

    $2.24M
    ENVB annual cash & cash equivalents is $2.24 million

    Accounts receivable

    -
    ENVB annual accounts receivable value is unknown

    Inventory

    $0.00
    ENVB annual inventory is $0.00

    Liabilities

    Total liabilities

    $1.49M
    ENVB annual total liabilities is $1.49 million

    Long term liabilities

    $0.00
    ENVB annual total long term liabilities is $0.00

    Current liabilities

    $1.49M
    ENVB annual total current liabilities is $1.49 million

    Accounts payable

    $521.70K
    ENVB annual accounts payable is $521.70 thousand

    Debt

    Total debt

    $0.00
    ENVB annual total debt is $0.00

    Total debt 1-year change

    0%
    ENVB annual total debt has remained unchanged year-on-year

    Long term debt

    $0.00
    ENVB annual long term debt is $0.00

    Short term debt

    $0.00
    ENVB annual short term debt is $0.00

    Equity & Capital

    Shareholders equity

    $1.59M
    ENVB annual stockholders equity is $1.59 million

    Book value

    $1.59M
    ENVB annual book value is $1.59 million

    Retained earnings

    -$106.07M
    ENVB annual retained earnings is -$106.07 million

    Working capital

    $1.24M
    ENVB annual working capital is $1.24 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$7.73M
    ENVB annual cash flow from operations is -$7.73 million

    Cash from operations 1-year change

    +45.18%
    ENVB annual cash flow from operations is up +45.18% year-on-year

    Cash from investing

    $0.00
    ENVB annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    -100%
    ENVB annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $7.67M
    ENVB annual cash flow from financing activities is $7.67 million

    Cash from financing 1-year change

    +671.35%
    ENVB annual cash flow from financing activities is up +671.35% year-on-year

    CAPEX

    CAPEX

    $0.00
    ENVB annual capital expenditures is $0.00

    CAPEX 1-year change

    -100%
    ENVB annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free cash flow

    -$7.73M
    ENVB annual free cash flow is -$7.73 million

    Free cash flow 1-year change

    +45.2%
    ENVB annual free cash flow is up +45.2% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ENVB annual gross profit margin value is unknown

    Operating margin

    -
    ENVB annual operating profit margin value is unknown

    Net margin

    -
    ENVB annual net profit margin value is unknown

    ROA & ROE

    ROA

    -208.15%
    ENVB annual return on assets is -208.15%

    ROE

    -356.82%
    ENVB annual return on equity is -356.82%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ENVB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ENVB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.34
    ENVB price to book ratio is 1.34

    PB ratio Sector rank

    41.92%
    ENVB price to book ratio is higher than 41.92% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ENVB price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ENVB price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $68.62K
    ENVB enterprise value is $68.62 thousand

    Enterprise value Sector rank

    11.91%
    ENVB enterprise value is higher than 11.91% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.01
    ENVB EV/EBITDA is -0.01

    EV/EBITDA Sector rank

    63.12%
    ENVB EV/EBITDA is higher than 63.12% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.84
    ENVB annual current ratio is 1.84

    Quick ratio

    1.84
    ENVB annual quick ratio is 1.84

    Leverage

    Debt to equity

    0.00
    ENVB annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ENVB annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ENVB piotroski f-score value is unknown

    Altman Z-Score

    -56.83
    ENVB altman z-score is -56.83

    Analyst ratings

    Recent major analysts updates

    Mar 6, 25 HC Wainwright & Co.
    Buy
    Jan 30, 24 HC Wainwright & Co.
    Buy
    Jun 1, 22 Alliance Global Partners
    Buy
    Mar 8, 22 Aegis Capital
    Hold
    Jul 8, 21 Aegis Capital
    Buy
    Jun 28, 21 Maxim Group
    Buy

    Institutional Ownership

    Screeners with ENVB included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Enveric Biosciences, Inc.?
    • Does Enveric Biosciences, Inc. pay dividends?
    • What sector is Enveric Biosciences, Inc. in?
    • What industry is Enveric Biosciences, Inc. in?
    • What country is Enveric Biosciences, Inc. based in?
    • When did Enveric Biosciences, Inc. go public?
    • Is Enveric Biosciences, Inc. in the S&P 500?
    • Is Enveric Biosciences, Inc. in the NASDAQ 100?
    • Is Enveric Biosciences, Inc. in the Dow Jones?
    • When was Enveric Biosciences, Inc.'s last earnings report?
    • When does Enveric Biosciences, Inc. report earnings?

    What is the ticker symbol for Enveric Biosciences, Inc.?

    The ticker symbol for Enveric Biosciences, Inc. is NASDAQ:ENVB

    Does Enveric Biosciences, Inc. pay dividends?

    No, Enveric Biosciences, Inc. does not pay dividends

    What sector is Enveric Biosciences, Inc. in?

    Enveric Biosciences, Inc. is in the Healthcare sector

    What industry is Enveric Biosciences, Inc. in?

    Enveric Biosciences, Inc. is in the Biotechnology industry

    What country is Enveric Biosciences, Inc. based in?

    Enveric Biosciences, Inc. is headquartered in United States

    When did Enveric Biosciences, Inc. go public?

    Enveric Biosciences, Inc.'s initial public offering (IPO) was on May 4, 2015

    Is Enveric Biosciences, Inc. in the S&P 500?

    No, Enveric Biosciences, Inc. is not included in the S&P 500 index

    Is Enveric Biosciences, Inc. in the NASDAQ 100?

    No, Enveric Biosciences, Inc. is not included in the NASDAQ 100 index

    Is Enveric Biosciences, Inc. in the Dow Jones?

    No, Enveric Biosciences, Inc. is not included in the Dow Jones index

    When was Enveric Biosciences, Inc.'s last earnings report?

    Enveric Biosciences, Inc.'s most recent earnings report was on August 14, 2025

    When does Enveric Biosciences, Inc. report earnings?

    The next expected earnings date for Enveric Biosciences, Inc. is November 14, 2025
    On this page